Address
Amstelkade 39A
3652 ME Woerdense Verlaat
The Netherlands
The Netherlands
Contact
Leonie de Best+31610961454
leonie.debest@madam-therapeutics.com
Website
Novel antimicrobial peptides
Madam Therapeutics is developing novel antibiotics to fight antimicrobial resistance
Very effective and safe antimicrobial peptides identified using Artificial intelligence.
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial compound/strategy
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- Environmental
- Other
- AgriFood
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Outsource
- Joint Venture
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Prefferably investor or codevelopment/lisence partner with infectious diseases expertise or background
Madam Therapeutics is an innovative biotech company that develops novel antimicrobial therapies to fight antimicrobial resistance (AMR).
They have a very rapid killing effect by disrupting their cell membrane. Broad spectrum, also against multidrug and PAN drug resistant bacteria
